Pedro C. Rodríguez

468 total citations
10 papers, 212 citations indexed

About

Pedro C. Rodríguez is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pedro C. Rodríguez has authored 10 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pedro C. Rodríguez's work include Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and vaccines and immunoinformatics approaches (3 papers). Pedro C. Rodríguez is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and vaccines and immunoinformatics approaches (3 papers). Pedro C. Rodríguez collaborates with scholars based in Cuba and Belgium. Pedro C. Rodríguez's co-authors include Agustín Lage, Gisela González, Beatriz García Verdecia, Tania Crombet, Patricia Hernández, Ernesto Moreno, Enrique Montero, Elia Nenínger Vinageras, Agustín Lage Dávila and Elia Neninger and has published in prestigious journals such as Journal of Clinical Oncology, Vaccine and OncoImmunology.

In The Last Decade

Pedro C. Rodríguez

10 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro C. Rodríguez Cuba 7 138 109 72 29 27 10 212
Richard Wnek United States 10 141 1.0× 143 1.3× 89 1.2× 24 0.8× 22 0.8× 14 284
Donghoon Choi South Korea 10 208 1.5× 173 1.6× 54 0.8× 17 0.6× 22 0.8× 19 314
Coreen Oei United States 5 152 1.1× 82 0.8× 101 1.4× 28 1.0× 7 0.3× 7 232
Werner Frings United States 5 114 0.8× 70 0.6× 49 0.7× 8 0.3× 86 3.2× 10 211
Amy E. Gilbert United Kingdom 7 122 0.9× 79 0.7× 76 1.1× 11 0.4× 86 3.2× 11 256
Laura T. Morton Netherlands 8 153 1.1× 184 1.7× 84 1.2× 11 0.4× 12 0.4× 12 273
Julie‐Ann Francis Canada 8 183 1.3× 134 1.2× 101 1.4× 39 1.3× 6 0.2× 11 347
Pablo Ramos Spain 10 210 1.5× 272 2.5× 62 0.9× 49 1.7× 12 0.4× 15 380
Gabrielle T. Prince United States 9 80 0.6× 114 1.0× 82 1.1× 8 0.3× 10 0.4× 28 263
Michael Atkins United States 7 177 1.3× 178 1.6× 121 1.7× 16 0.6× 11 0.4× 13 310

Countries citing papers authored by Pedro C. Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Pedro C. Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro C. Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro C. Rodríguez more than expected).

Fields of papers citing papers by Pedro C. Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro C. Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro C. Rodríguez. The network helps show where Pedro C. Rodríguez may publish in the future.

Co-authorship network of co-authors of Pedro C. Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro C. Rodríguez. A scholar is included among the top collaborators of Pedro C. Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro C. Rodríguez. Pedro C. Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Verdecia, Beatriz García, Vivian Huerta, Carmen Viada, et al.. (2020). Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule. OncoImmunology. 9(1). 1762465–1762465. 9 indexed citations
2.
Sánchez, Lizet, Leacky Muchene, Patricia Lorenzo-Luaces, et al.. (2018). Differential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer. Seminars in Oncology. 45(1-2). 52–57. 6 indexed citations
3.
Hernández, Patricia, et al.. (2016). Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab. Current Drug Targets. 17(6). 666–677. 27 indexed citations
4.
Crombet, Tania, Pedro C. Rodríguez, Elia Nenínger Vinageras, Beatriz García Verdecia, & Agustín Lage Dávila. (2015). CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer. Expert Review of Vaccines. 14(10). 1303–1311. 25 indexed citations
5.
Crombet, Tania, Elia Neninger, Pedro C. Rodríguez, et al.. (2013). EGF-based cancer vaccine: Optimizing predictive and surrogate biomarkers.. Journal of Clinical Oncology. 31(15_suppl). 3013–3013. 6 indexed citations
6.
Rodríguez, Pedro C., Gil Reyes, M.V. Hernández, et al.. (2012). A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis. PubMed. 2. 204–211. 33 indexed citations
7.
Crombet, Tania, Elia Neninger, Silvia Mendoza, et al.. (2012). EGF-based cancer vaccine for advanced NSCLC: Results from a phase III trial.. Journal of Clinical Oncology. 30(15_suppl). 2527–2527. 2 indexed citations
8.
9.
Rodríguez, Pedro C., et al.. (2010). Clinical Development and Perspectives of CIMAvax EGF, Cuban Vaccine for Non-small-cell Lung Cancer Therapy. MEDICC Review. 12(1). 17–17. 64 indexed citations
10.
Rodríguez, Pedro C., et al.. (2008). Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine. Vaccine. 26(36). 4647–4654. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Wnek Breakdown of academic impact, for papers by Donghoon Choi Breakdown of academic impact, for papers by Coreen Oei Breakdown of academic impact, for papers by Werner Frings Breakdown of academic impact, for papers by Amy E. Gilbert Breakdown of academic impact, for papers by Laura T. Morton Breakdown of academic impact, for papers by Julie‐Ann Francis Breakdown of academic impact, for papers by Pablo Ramos Breakdown of academic impact, for papers by Gabrielle T. Prince Breakdown of academic impact, for papers by Michael Atkins
Rankless by CCL
2026